Global EditionASIA 中文双语Français
China
Home / China / Top News

Xi's speech at CIIE draws positive reactions

By He Wei, Ren Xiaojin, Ouyang Shijia, Zheng Xin, Liu Zhihua, Zhang Chunyan, Wang Ying and Wang Xiaodong and Shi Jing | chinadaily.com.cn | Updated: 2018-11-05 14:51
Share
Share - WeChat
Jean-Christophe Pointeau, Country Chair of Sanofi China. [Photo provided to chinadaily.com.cn]

Jean-Christophe Pointeau, Country Chair of Sanofi China

Sanofi greatly appreciates President Xi's confidence in bolstering opening-up and fostering collaboration. As one of the first multinational pharma companies to have presence in China, we have always been committed to playing an active role in the country's healthcare ecosystem over the past 36 years. President Xi said the Chinese economy is a sea. As the world's leading healthcare company and an outstanding corporate citizen, Sanofi, together with our 9,500 employees, will be dedicated to our mission and strive to safeguard the health of Chinese people.

Sanofi is accelerating the development and introduction of new drugs. By 2025, at least 16 new products and indications are expected to be launched in China, especially in the areas of cancer, chronic diseases, rare diseases and vaccination.

Sanofi is also actively responding to the Belt and Road Initiative. Prior to the CIIE, Sanofi launched the China Health Road Program which targets primary healthcare in China, with a package plan to provide long-term training for general practitioners starting in seven cities. By 2020, the program will cover 94 percent of the areas along the Belt and Road in China. At the CIIE, Sanofi will also hold the China Health Road Symposium.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US